Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity
Giannoula Klement, … , Peter Bohlen, Robert S. Kerbel
Giannoula Klement, … , Peter Bohlen, Robert S. Kerbel
Published November 1, 2006
Citation Information: J Clin Invest. 2006;116(11):3084-3084. https://doi.org/10.1172/JCI82691.
View: Text | PDF | Amended Article
Corrigendum

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

Abstract

Authors

Giannoula Klement, Sylvain Baruchel, Janusz Rak, Shan Man, Katherine Clark, Daniel J. Hicklin, Peter Bohlen, Robert S. Kerbel

×

Options: View larger image (or click on image) Download as PowerPoint